Read + Share

Amedeo Smart

Independent Medical Education


Read + Share

Ridker PM, MacFadyen JG, Everett BM, Libby P, et al. Relationship of C-reactive protein reduction to cardiovascular event reduction following treatment with canakinumab: a secondary analysis from the CANTOS randomised controlled trial. Lancet 2017 Nov 13. pii: S0140-6736(17)32814.
PMID: 29146124


Free Medical Abstracts
Privacy Policy
Sponsors
Share
About

© Amedeo 1997-2016